Lung Cancer

Top Story

Durvalumab reduces local, distant progression in non-small cell lung cancer

Durvalumab reduces local, distant progression in non-small cell lung cancer
September 19, 2019

Read the Perspective from Mohamed Abazeed, MD, PhD

In the Journals

Palliative care linked to survival benefit in advanced lung cancer

September 19, 2019
Palliative care appeared associated with survival benefits among patients with advanced lung cancer, according to results of a retrospective study published in JAMA
Meeting NewsPerspective

Single-agent, targeted therapies induce negligible response among smokers with NSCLC

September 19, 2019
BARCELONA — Targeted therapies for non-small cell lung cancer demonstrated potential benefit in additional molecular stratifications of the disease, according to…
Feature

AACR Cancer Progress Report: Past federal investments in NIH spurring breakthroughs in care

September 18, 2019
The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is paying dividends in…
More Headlines »
CME ABIM MOC

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »
Video
Meeting News

VIDEO: RET inhibitor shows promise in advanced NSCLC

June 15, 2019
More »
Resource Centers
Discoveries from ASCO Lung Cancer

Discoveries from ASCO Lung Cancer

CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »